Royalty Pharma said on Tuesday will pay up to $2 billion to Revolution Medicines to support the companies' plans for global development and commercialization of the experimental cancer drug ...

Big Pharma often pushes the most expensive iteration of a drug; cheaper remedies are available. And they promote the idea ...

WILMINGTON, DE, UNITED STATES, June 20, 2025 /EINPresswire.com/ -- According to industry analysts at Stellar Market Research that the Fertility Supplements Market is demonstrating ...

This growth can be attributed to the escalating demand for pediatric-friendly drug formulations, increasing prevalence of pain-related conditions, and rising acceptance of orally disintegrating ...

Get all latest & breaking news on Hg Infra Engineering. Watch videos, top stories and articles on Hg Infra Engineering at moneycontrol.com.

Stocks To Buy: On Tuesday (June 10), domestic equity benchmarks ended a choppy session largely flat.The Sensex declined 53.5 points, or 0.1 per cent, to end at 82,391.7 while the Nifty50 settled at 25 ...

Mankind Pharma has allotted 57,709 equity shares of face value of Re. 1/- each of the Company to the eligible employees who have exercised their options pursuant to the ESOP Plan. Consequent to the ...

Satellite images show Russia tried using deceptive tactics at the airbases Ukraine attacked Sunday. These tactics included placing tires on wings and painting fake decoy planes on the ground. It's ...

Sterling will manufacture cGMP clinical material for KIVU-107 at its bioconjugation facility in Deeside, UK. Kivu Bioscience, a biotech company developing next-gen antibody-drug conjugates (ADCs), ...

Bristol Myers Squibb will license a cutting-edge cancer drug from BioNTech for as much as $11.1 billion, according to Bloomberg. The German company’s drug encourages the immune system to attack ...

Mankind Pharma Background - Read about Mankind Pharma, its background on The Economic Times. Benchmarks . Nifty 24,750.70-82.9. FEATURED FUNDS ...